Scientists test first-ever therapy to make human cells young again
Human trials have officially commenced for the first-ever gene therapy designed to rejuvenate human cells and reverse aging.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Human trials began for a gene therapy aimed at cell rejuvenation and reversing aging. Ron DePinho described the effort as a milestone in cellular reprogramming.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 10d ago, after coverage quieted.
The brief
Scientists have launched the first human trials for a gene therapy focused on cell rejuvenation. The initiative aims to test whether cellular reprogramming can make human cells young again.
Coverage from Yahoo, Times Now, and inkorr emphasizes that this represents a new milestone in the field. Oncodaily specifically attributes this development to Ron DePinho.
Future developments depend on the outcomes of these trials to determine if science can effectively help humans reverse aging, as questioned by the Dallas Express.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 26d ago.
Quick answers
What is being tested in these trials?
A gene therapy aimed at cell rejuvenation and cellular reprogramming to make human cells young again.
Who is associated with this milestone?
According to Oncodaily, Ron DePinho is linked to this milestone in cellular reprogramming.
Has the therapy been proven successful?
Coverage indicates that human trials have begun, but does not specify the results of the testing.
Coverage (5)
- Human Trials Begin for Gene Therapy Aimed at Cell Rejuvenation inkorr.com · 27d ago
- Can Science Help Humans Reverse Aging? Dallas Express · 27d ago
- The World’s First ‘Reverse-Ageing’ Human Trial Has Begun Times Now · 27d ago
- Ron DePinho: A New Milestone in Cellular Reprogramming Oncodaily · 27d ago
- Scientists test first-ever therapy to make human cells young again Yahoo · 27d ago
Topics
Related trends
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
MeiraGTx has secured significant new funding from Oberland Capital to advance two gene therapies toward commercialization.
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
Louisiana Notches a Sickle Cell First
A Louisiana man is the first in the state to be functionally cured of sickle cell disease.
Celeb-Loved Beauty Products on Sale for Prime Day
Amazon Prime Day is underway, with beauty products endorsed by celebrities and experts seeing significant discounts.
Exclusive | FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The FDA is reversing its rejection of Regenxbio's gene therapy for Hunter syndrome, marking the third such reversal for rare-disease drugs.